Life Cycle and Quality by Design for Chromatographic Methods
February 1st 2014A recent stimulus to the review process article by the United States Pharmacopoeia (USP) Expert Committee is proposing a major change in the way regulated laboratories develop, validate and control analytical procedures. Is this Quality by Design (QbD) for the chromatography laboratory?
LCGC TV: Do We Need More LC Stationary Phases?
January 30th 2014Superficially porous particles for HPLC columns ? often called ?core?shell? particles ? have gotten a lot of attention in recent years because of their excellent performance. Yet so far, columns made with fully porous particles are still the most widely used. Will superficially porous particles eventually take over?
Thermo Fisher Scientific Sells Assets to Expedite Life Technologies Acquisition
January 30th 2014Thermo Fisher Scientific (California, USA) has signed an agreement with GE Healthcare (St Giles, UK) to sell business assets for $1.06 billion. Thermo Fisher committed to sell its cell culture, gene modulation, and magnetic beads businesses in 2013 to expedite approval of its pending acquisition of Life Technologies by the European Commission.
Eurofins CEO Gilles Martin Appointed to Bruker Board of Directors
January 23rd 2014Gilles Martin, Chairman and Chief Executive Officer of the Eurofins Scientific Group (Luxembourg, Luxembourg), has been elected to the Bruker Board of Directors (Massachusetts, USA). Martin founded the original Eurofins Scientific Nantes food authenticity laboratory in 1988, and is a past President of the French Association of private analytical laboratories, and the North American Technical Committee for Juice and Juice Products.
LCGC TV: Fully Porous vs. Superficially Porous Particles
January 23rd 2014Superficially porous particles for HPLC columns ? often called ?core?shell? particles ? have gotten a lot of attention in recent years because of their excellent performance. Yet so far, columns made with fully porous particles are still the most widely used. Will superficially porous particles eventually take over?
GC–MS investigates cheese made from human bacteria
January 21st 2014Researcher Christina Agapakis from the University of California, Los Angeles, USA, has come up with an unusual way of making cheese by taking bacteria from various parts of the human body and analyzing the odour of each cheese produced using headspace gas chromatography?mass spectrometry (GC?MS).
Duke Molecular Physiology Institute Receives Agilent Grant
January 16th 2014Agilent Technologies (California, USA) has awarded a grant to the Duke Molecular Physiology Institute, Duke University (North Carolina, USA) to support the research of the metabolic and physiological aspects of major chronic diseases such as cardiovascular disease. The institute researchers perform a range of analytical chemistry techniques, including liquid chromatography and gas chromatography coupled to mass spectrometry, to characterize molecular pathways in disease.
Fred Strohmeier Promoted to Agilent Senior VP and President of Life Sciences and Diagnostics Group
January 9th 2014Agilent Technologies (California, USA) has announced the promotion of Fred Strohmeier, vice president and general manager of Agilent's Life Science Products and Solutions, to senior vice president, Agilent, and president of Agilent's Life Sciences and Diagnostics Group (LDG), effective immediately.
Thermo Fisher Scientific Sells Assets to Expedite Life Technologies Acquisition
January 9th 2014Thermo Fisher Scientific (California, USA) has signed an agreement with GE Healthcare (St Giles, UK) to sell business assets for $1.06 billion. Thermo Fisher committed to sell its cell culture, gene modulation, and magnetic beads businesses in 2013 to expedite approval of its pending acquisition of Life Technologies by the European Commission.
Black Diamond of the Food World
January 9th 2014A study published in the Journal of Proteome Research has uncovered some of the proteins responsible for the characteristic aroma and taste of the black P?rigord truffle (Tuber melanosporum Vittad.), using a combined approach of bioinformatics and proteomic analysis.1